Innate Pharma buy metanicnor
Start price
07.09.14
/
50%
€8.63
Target price
09.03.15
€10.50
Performance (%)
19.99%
End price
09.03.15
€10.35
Summary
This prediction ended on 09.03.15 with a price of €10.35. The BUY prediction by metanicnor finished with a performance of 19.99%. metanicnor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innate Pharma | 1.246% | 1.246% | -8.402% | -36.415% |
| iShares Core DAX® | 1.043% | -0.149% | 34.887% | 71.440% |
| iShares Nasdaq 100 | 1.920% | 4.604% | 18.366% | 56.060% |
| iShares Nikkei 225® | 4.840% | 8.328% | 10.637% | 19.130% |
| iShares S&P 500 | 1.567% | 3.310% | 13.043% | 37.522% |
Comments by metanicnor for this prediction
In the thread Innate Pharma diskutieren
IPH Kauf
eines der wenigen Biotech-Unternehmen in der Welt auf der angeborenen Immunität positioniert
das Geld wird es ermöglichen, halten die Ende 2017
(Laufzeit überschritten)